X4 Pharmaceuticals, Inc
XFOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501697
In the last 90 days, X4 Pharmaceuticals, Inc insiders filed 0 open-market purchases and 3 sales; 89 institutions reported holding it in 13F filings for Q2 2026, worth $463.0M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in X4 Pharmaceuticals, Inc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 54
- −3 vs. Q3 2022
- Shares held
- 60.6M
- +21.8M (+56.2%) vs. Q3 2022
- Total value
- $60.2M
- −$6.17M (−9.3%) vs. Q3 2022
- New holders
- 10
- 20 more added
- Sold out
- 13
- 9 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XFOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 89 | $463.0M |
| Q1 2026 | 84 | $388.1M |
| Q4 2025 | 79 | $357.7M |
| Q3 2025 | 42 | $55.3M |
| Q2 2025 | 52 | $5.33M |
| Q1 2025 | 94 | $23.3M |
| Q4 2024 | 90 | $73.2M |
| Q3 2024 | 98 | $67.3M |
| Q2 2024 | 99 | $58.9M |
| Q1 2024 | 98 | $143.2M |
| Q4 2023 | 93 | $81.2M |
| Q3 2023 | 91 | $122.6M |
| Q2 2023 | 96 | $219.1M |
| Q1 2023 | 59 | $53.6M |
| Q4 2022 | 54 | $60.2M |
| Q3 2022 | 59 | $66.9M |
| Q2 2022 | 51 | $15.5M |
| Q1 2022 | 56 | $28.6M |
| Q4 2021 | 52 | $40.2M |
| Q3 2021 | 52 | $85.7M |
| Q2 2021 | 63 | $107.8M |
| Q1 2021 | 61 | $138.7M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding X4 Pharmaceuticals, Inc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rockefeller Capital Management L.P. | 1,000 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 9 | $9 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 272 | $270 | 0.00% | +271+27,100.0% | Added |
| Wells Fargo & Company | 427 | $424 | 0.00% | −152−26.3% | Reduced |
| High Net Worth Advisory Group LLC | 1,100 | $1.09K | 0.00% | 00.0% | Unchanged |
| Clearstead Advisors, LLC | 2,100 | $2.08K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 4,000 | $3.97K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 4,969 | $5.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 10,227 | $10.0K | 0.00% | +10,227 | New |
| Cutler Group LP | 12,200 | $12.0K | 0.00% | +11,700+2,340.0% | Added |
| Veritable, L.P. | 12,637 | $12.5K | 0.00% | 00.0% | Unchanged |
| Ronald Blue Trust, Inc. | 8,520 | $15.0K | 0.00% | 00.0% | Unchanged |
| Invesco Ltd. | 15,614 | $15.5K | 0.00% | +15,614 | New |
| LexAurum Advisors, LLC | 16,000 | $15.9K | 0.01% | 00.0% | Unchanged |
| Simplex Trading, LLC | 18,324 | $18.0K | 0.00% | +7,087+63.1% | Added |
| Group One Trading, L.P. | 20,180 | $20.0K | 0.00% | −12,696−38.6% | Reduced |
| PEAK6 Investments LLC | 20,200 | $20.1K | 0.00% | −40,000−66.4% | Reduced |
| Two Sigma Investments, LP | 22,102 | $21.9K | 0.00% | +22,102 | New |
| Commonwealth Equity Services, LLC | 22,500 | $22.0K | 0.00% | +22,500 | New |
| The PNC Financial Services Group, Inc. | 31,057 | $30.8K | 0.00% | 00.0% | Unchanged |
| Bleichroeder LP | 35,730 | $35.5K | 0.01% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 36,078 | $35.8K | 0.00% | −22,682−38.6% | Reduced |
| Charles Schwab Investment Management Inc | 42,386 | $42.1K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 54,980 | $54.6K | 0.00% | −400−0.7% | Reduced |
| Dimensional Fund Advisors LP | 59,309 | $59.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 76,057 | $75.5K | 0.00% | +18,820+32.9% | Added |
| Stifel Financial Corp | 81,996 | $81.4K | 0.00% | +14,673+21.8% | Added |
| Renaissance Technologies LLC | 94,794 | $94.0K | 0.00% | −147,400−60.9% | Reduced |
| JPMorgan Chase & Co | 119,598 | $119.0K | 0.00% | +119,598 | New |
| Northern Trust Corp | 146,713 | $145.7K | 0.00% | +61,526+72.2% | Added |
| State Street Corp | 170,633 | $169.4K | 0.00% | +115,900+211.8% | Added |
| Bank of New York Mellon Corp | 171,193 | $170.0K | 0.00% | +31,497+22.5% | Added |
| BlackRock Inc. | 274,686 | $272.8K | 0.00% | −14,697−5.1% | Reduced |
| New Leaf Venture Partners, L.L.C. | 335,000 | $332.7K | 0.24% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 349,133 | $346.7K | 0.14% | −219,479−38.6% | Reduced |
| Geode Capital Management, LLC | 587,516 | $583.0K | 0.00% | +93,859+19.0% | Added |
| Point72 Asset Management, L.P. | 650,000 | $645.5K | 0.00% | −1,896,446−74.5% | Reduced |
| Schonfeld Strategic Advisors LLC | 895,300 | $889.0K | 0.01% | +895,300 | New |
| Citadel Advisors LLC | 944,853 | $938.2K | 0.00% | +944,853 | New |
| Ghost Tree Capital, LLC | 1,000,000 | $993.0K | 0.42% | +1,000,000 | New |
| Millennium Management LLC | 1,153,433 | $1.15M | 0.00% | +1,040,469+921.1% | Added |
| BVF Inc | 1,347,650 | $1.34M | 0.06% | +499,771+58.9% | Added |
| Cormorant Asset Management, LP | 1,628,980 | $1.62M | 0.11% | +798,326+96.1% | Added |
| Sio Capital Management, LLC | 1,825,963 | $1.81M | 0.97% | +407,502+28.7% | Added |
| Lynwood Capital Management Inc. | 2,155,100 | $2.14M | 2.58% | +2,155,100 | New |
| Parkman Healthcare Partners LLC | 2,375,557 | $2.36M | 0.63% | +1,425,557+150.1% | Added |
| CVI Holdings, LLC | 2,381,923 | $2.37M | 0.30% | +2,381,923 | New |
| Vanguard Group Inc | 3,580,389 | $3.56M | 0.00% | +372,286+11.6% | Added |
| Tri Locum Partners LP | 3,706,517 | $3.68M | 1.63% | +1,202,511+48.0% | Added |
| AXA S.A. | 4,361,641 | $4.33M | 0.02% | +235,181+5.7% | Added |
| OrbiMed Advisors LLC | 5,817,726 | $5.78M | 0.11% | +790,909+15.7% | Added |
| NEA Management Company, LLC | 11,736,793 | $11.7M | 0.65% | +5,213,636+79.9% | Added |
| Bain Capital Life Sciences Investors, LLC | 12,202,510 | $12.1M | 1.35% | +5,813,074+91.0% | Added |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −997,719−100.0% | Sold out |
| Worth Venture Partners, LLC | 0 | $0 | 0.00% | −250,144−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −150,597−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −45,000−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −33,000−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −23,065−100.0% | Sold out |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −13,221−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Moody Lynn & Lieberson, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Dynamic Advisor Solutions LLC | 0 | $0 | 0.00% | −10,100−100.0% | Sold out |
| Mayflower Financial Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −9,525−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −101−100.0% | Sold out |
| SV Health Investors, LLC | – | – | – | – | Not filed |
| American Portfolios Advisors | – | – | – | – | Not filed |